Thus, LDLR could serve as one of the most prospective targets of gene therapy of atherosclerosis with different options related to the delivery of more copies of this gene and/or gene editing in case of need for the correction of mutations affecting blood cholesterol levels. This evidence concerns the gene LDLR and atherosclerosis.